Recombinant Bovine Transmembrane protein 108 (TMEM108)

What is the basic structure and characteristics of bovine TMEM108?

Recombinant Full Length Bovine Transmembrane protein 108 (TMEM108) is a 555 amino acid protein (spanning positions 29-583 of the mature protein) that functions as a transmembrane protein in mammalian systems. When produced recombinantly, it is typically expressed with an N-terminal His tag in E. coli expression systems. The protein exists as a lyophilized powder with >90% purity as determined by SDS-PAGE. The amino acid sequence includes multiple transmembrane domains characteristic of membrane proteins that span the lipid bilayer .

What is the gene synonymy and identification for bovine TMEM108?

The bovine TMEM108 gene is also known as Retrolinkin in scientific literature. Its UniProt ID is A6QLF8, which serves as the standard reference identifier in protein databases. This identification is essential for accurate cross-referencing when designing experiments or comparing results with published studies on TMEM108 from different species .

How is TMEM108 expression regulated during development?

TMEM108 expression shows distinct developmental patterns, particularly in the central nervous system. Studies have demonstrated that TMEM108 expression in the corpus callosum is higher in young mice compared to adult mice. This suggests age-dependent regulation of TMEM108 expression, with higher levels during developmental periods associated with active myelination. The protein colocalizes with oligodendrocytes in young mice corpus callosum, indicating a potential role in developmental myelination processes .

What are appropriate storage and reconstitution methods for recombinant TMEM108?

For optimal results, briefly centrifuge the vial before opening to collect contents at the bottom. After reconstitution, adding glycerol (typically to a final concentration of 50%) and creating multiple small aliquots is recommended to prevent protein degradation during freeze-thaw cycles .

What are the validated applications for recombinant bovine TMEM108?

Recombinant bovine TMEM108 has been validated for SDS-PAGE applications, making it suitable for protein expression studies, antibody production, and initial characterization experiments. While specific applications may be limited in the current literature, researchers can reasonably extend its use to protein-protein interaction studies, structural analyses, and as a control or standard in assays measuring endogenous TMEM108 levels. For novel applications, preliminary validation experiments are recommended to ensure the recombinant protein maintains relevant biological activities .

How can researchers verify the functionality of recombinant TMEM108?

Functional verification of recombinant TMEM108 can be accomplished through multiple complementary approaches:

• Structural integrity assessment: SDS-PAGE under reducing and non-reducing conditions to confirm expected molecular weight and potential oligomerization

• Binding partner validation: Co-immunoprecipitation or pull-down assays with known interaction partners

• Antibody recognition: Western blot using validated anti-TMEM108 antibodies

• Cell-based assays: Transfection of the recombinant protein to rescue phenotypes in TMEM108-knockout cell lines

• Comparative analyses: Parallel testing with commercially available TMEM108 proteins from other vendors as positive controls

These methodological approaches provide multiple lines of evidence for proper folding and functional capacity of the recombinant protein .

What cell types are most appropriate for TMEM108 functional studies?

Based on expression pattern data, oligodendrocyte lineage cells represent the most physiologically relevant cell types for TMEM108 functional studies. TMEM108 is expressed at higher levels in oligodendrocyte lineage cells compared to other cell types in the central nervous system. Specific cell populations of interest include:

• Oligodendrocyte progenitor cells (OPCs, PDGFRα+Olig2+ cells)

• Newly formed oligodendrocytes (highest expression cell type)

• Mature oligodendrocytes (CC1+ cells)

For developmental studies, comparing effects in cells isolated from different age groups would be valuable, as TMEM108 expression changes from predominantly OPC expression at P7 to a broader distribution among oligodendrocyte lineage cells at P14 .

How does TMEM108 influence oligodendrocyte development and myelination?

TMEM108 appears to function as a negative regulator of oligodendrocyte development and myelination. Research using TMEM108 mutant mice has revealed several key findings:

• OPC proliferation is enhanced in TMEM108 mutant mice

• Oligodendrocyte myelination is increased in the absence of functional TMEM108

• TMEM108 specifically inhibits OPC proliferation and mitigates maturation of corpus callosum oligodendrocytes

• TMEM108 prevents myelination of small-diameter axons

• Expression of myelin basic protein (MBP) is elevated in TMEM108 mutant mice

These findings suggest that TMEM108 functions as a developmental brake on myelination processes, potentially ensuring appropriate timing and targeting of myelination. Researchers studying oligodendrocyte biology should consider TMEM108 as a potential regulatory target when investigating myelination disorders .

What experimental approaches can be used to study TMEM108's role in metabolic regulation?

Implementation of these complementary approaches provides comprehensive assessment of TMEM108's influence on metabolic homeostasis. Research has demonstrated that TMEM108 mutant mice exhibit glucose intolerance, insulin resistance, and disturbed metabolic homeostasis, indicating a previously unrecognized role for this protein in regulating metabolism .

What are the methodological considerations when studying TMEM108 in relation to neuropsychiatric disorders?

When investigating TMEM108's role in neuropsychiatric disorders such as bipolar disorder and schizophrenia, researchers should implement multi-dimensional methodological approaches:

• Genetic analyses: Evaluate single nucleotide polymorphisms (SNPs) in non-coding regulatory regions of TMEM108, particularly rs9863544 located in the upstream regulatory region, which has been identified as a risk locus in Han Chinese populations

• Stress response protocols: Implement acute restraint stress paradigms, as TMEM108 mutant mice exhibit mania-like behaviors specifically after stress exposure

• Seizure susceptibility testing: Assess vulnerability to drug-induced epilepsy, as TMEM108 mutant mice show increased susceptibility

• Behavioral test battery: Include open field testing, rotarod performance, and specialized tests for mania-like behaviors

• White matter integrity assessment: Evaluate myelination patterns using electron microscopy and immunohistochemistry for myelin markers (e.g., MBP)

• Expression analyses across development: Compare TMEM108 expression in different brain regions at multiple developmental timepoints

These approaches capture the complex interplay between TMEM108 function, white matter integrity, and behavioral phenotypes relevant to neuropsychiatric disorders .

How should researchers interpret contradictory findings related to TMEM108 function?

When encountering apparently contradictory findings regarding TMEM108 function, researchers should consider several factors:

• Developmental context: TMEM108 expression and function change significantly during development, with different effects at early versus later stages

• Cell type specificity: TMEM108 may exert distinct effects in different cell populations (e.g., effects in oligodendrocytes versus neurons)

• Region-specific influences: Function may vary across brain regions (corpus callosum versus hippocampus, etc.)

• Species differences: Bovine TMEM108 may exhibit functional differences compared to mouse or human orthologs

• Methodological variations: Different knockout strategies (e.g., complete gene deletion versus specific exon targeting) may produce variable phenotypes

• Compensatory mechanisms: Long-term absence of TMEM108 may trigger compensatory pathways not present in acute inhibition studies

What gene-edited mouse models are available for TMEM108 research?

The primary gene-edited mouse model used in TMEM108 research is the TMEM108-LacZ knockout mouse (MMRRC: 032633-UCD). In this model, the first coding exon of TMEM108 (exon 3) is replaced with a β-galactosidase/neomycin cassette through homologous recombination. This cassette includes both a stop codon and a polyadenylation termination signal, effectively preventing the expression of functional TMEM108 protein.

This model exhibits several key phenotypes that make it valuable for research:

• Mania-like behaviors, particularly after acute restraint stress

• Increased susceptibility to drug-induced epilepsy

• Enhanced oligodendrocyte progenitor cell proliferation

• Hypermyelination in the corpus callosum

• Glucose intolerance and insulin resistance

• Impaired fatigue resistance without motor coordination deficits

Researchers should house these mice in standard conditions with a 12-hour light/dark cycle at 22-25°C, with ad libitum access to food and water .

What cellular systems are optimal for studying recombinant bovine TMEM108?

When selecting cellular systems for recombinant bovine TMEM108 studies, researchers should consider the following options, listed in order of physiological relevance:

• Primary bovine oligodendrocyte cultures: Provide the most relevant cellular context but are technically challenging to establish and maintain

• Immortalized oligodendrocyte precursor cell lines: Offer a balance between relevance and experimental tractability

• HEK293 or CHO cells with controlled expression systems: Allow for detailed biochemical characterization in well-established cell lines

• Primary mixed glial cultures: Enable study of TMEM108 in the context of glial cell interactions

• Brain slice cultures: Preserve tissue architecture while allowing experimental manipulation

For functional studies, transfection or transduction of the recombinant protein into TMEM108-deficient cells provides the most interpretable system. For protein-protein interaction studies, heterologous expression systems like HEK293 cells may be preferable due to their high transfection efficiency and protein production capacity .

How can researchers effectively use RNA expression analysis to study TMEM108?

RNA expression analysis of TMEM108 requires careful methodological consideration:

• Sample preparation: Extract total RNA using TRIzol Reagent following manufacturer's instructions

• Quality control: Assess RNA integrity using gel electrophoresis or Bioanalyzer

• qPCR methodology: Implement real-time PCR with appropriate reference genes (β-Actin is commonly used)

• Data analysis: Calculate relative expression using the 2^-ΔΔCT method, normalizing mutant groups to control groups after setting controls to a value of 1

• Validation: Confirm primer specificity through melting curve analysis and verify PCR products via agarose gel electrophoresis

When analyzing TMEM108 expression across different brain regions or developmental stages, researchers should include cerebellum, thalamus, hippocampus, corpus callosum, cerebral cortex, striatum, prefrontal cortex, and olfactory bulb for comprehensive mapping of expression patterns .

What are the promising therapeutic applications targeting TMEM108?

Based on current understanding of TMEM108 function, several therapeutic applications warrant investigation:

• Demyelinating disorders: TMEM108 inhibition might promote remyelination in conditions like multiple sclerosis, given its role in inhibiting oligodendrocyte development

• Bipolar disorder treatment: Modulating TMEM108 activity could potentially address white matter abnormalities associated with bipolar disorder

• Metabolic syndrome interventions: TMEM108's involvement in glucose homeostasis suggests potential applications in metabolic disorders

• Anti-epileptic approaches: Understanding TMEM108's role in seizure susceptibility could inform novel anti-epileptic strategies

• Stress resilience enhancement: TMEM108 modulation might improve stress resilience in psychiatric conditions

For each application, researchers should develop specific compounds or strategies that can modulate TMEM108 activity in a targeted and controlled manner. Initial studies should focus on proof-of-concept experiments in relevant animal models before advancing to more translational research .

What technological advances would benefit TMEM108 structure-function research?

Several technological advances would significantly enhance our understanding of TMEM108 structure-function relationships:

• Cryo-electron microscopy: Determination of high-resolution 3D structure of TMEM108 in different conformational states

• Cell-specific and temporally controlled knockout models: CRISPR-Cas9 systems allowing oligodendrocyte-specific and temporally regulated TMEM108 deletion

• Optogenetic control of TMEM108 function: Light-activated domains fused to TMEM108 to enable precise temporal control of activity

• Single-cell multi-omics: Integration of transcriptomic, proteomic, and metabolomic data at single-cell resolution to map TMEM108 networks

• Advanced in vivo imaging: Two-photon microscopy techniques to visualize TMEM108-expressing cells in living brain tissue

• Protein interaction mapping: Proximity labeling approaches like BioID or APEX to identify the complete TMEM108 interactome

These technological approaches would provide unprecedented insights into how TMEM108 functions at the molecular, cellular, and systems levels .

How might TMEM108 research inform our understanding of the oligodendrocyte-neuron relationship?

TMEM108 research provides a unique window into oligodendrocyte-neuron interactions and could advance our understanding in several key areas:

• Axon diameter-specific myelination: TMEM108 appears to regulate myelination of small-diameter axons specifically, suggesting sophisticated mechanisms for axon selection during myelination

• Developmental timing of myelination: TMEM108's developmental regulation suggests it helps orchestrate the temporal progression of myelination

• Activity-dependent myelination: Future studies could explore whether TMEM108 responds to neuronal activity to regulate adaptive myelination

• Metabolic coupling: TMEM108's dual role in myelination and metabolism suggests it might coordinate metabolic support functions of oligodendrocytes

• Pathological vulnerability: Understanding why TMEM108 mutants show increased susceptibility to stress and seizures could reveal how glia-neuron interactions maintain circuit resilience

This research direction requires integrated approaches combining cell-type specific manipulations, electrophysiology, behavior, and metabolic analyses to fully elucidate TMEM108's role in maintaining proper communication between oligodendrocytes and neurons .